Human Papillomavirus

U.S. oral HPV prevalence near 7%

Higher prevalence of oral HPV in men than women, and peaks at ages 30 to 34 years and 60 to 64 years correlate with trends in oropharyngeal squamous-cell carcinoma incidence.

Doubts on HPV shots in men

Increasing HPV vaccine uptake among preadolescent girls is more effective in reducing HPV infection than including boys in existing vaccination programs would be, researchers from the Netherlands say.

Adolescents need HPV shots early

Common reasons that parents give when declining human papillomavirus vaccine for their children are, “My teen is not sexually active,” or “Maybe we’ll wait until he/she is a bit older.” This thinking negates the vaccine’s preventive purpose.

Next post in Commentary